Would the elderly be better off if they were given more placebos?

  title={Would the elderly be better off if they were given more placebos?},
  author={E. Paul Cherniack},
  journal={Geriatrics \& Gerontology International},
  • E. Cherniack
  • Published 1 April 2010
  • Medicine
  • Geriatrics & Gerontology International
Placebos are useful in the medical care of the elderly, although the exact definition of a “placebo” or “placebo effect” is difficult to define precisely. They have an important role as control treatments in research trials, but a non‐specific “placebo effect” may also be beneficial part of many physician–patient interactions. Physicians also give them deliberately according to several studies worldwide to satisfy patient demands or because they believe in a “placebo effect” among other reasons… 
The placebo effect in rheumatology: new data.
  • J. Berthelot
  • Psychology, Medicine
    Joint, bone, spine : revue du rhumatisme
  • 2011
Placebo analgesia: cognitive influences on therapeutic outcome
An overview for clinicians of the importance of contextual psychosocial variables in determining treatment response is provided, and the specific focus is on determinants of the placebo response.
Preserved Capacity for Placebo Analgesia in the Elderly.
Attempting to define placebos and their effects: A keywords approach
A Keywords approach is used to explore how the placebo, placebo effect and related concepts have been defined to date. The selected terms have become convenient receptacles for competing and
Placebos as a Source of Agency: Evidence and Implications
Bioethical discussions surrounding the use of placebos in clinical practice have long revolved around the moral permissibility of deceiving a patient if it is likely to benefit them. While these
Age and Sex as Moderators of the Placebo Response - An Evaluation of Systematic Reviews and Meta-Analyses across Medicine
Age and gender have been found to be reliable predictors of the PR across medical subspecialties, but sex does not, and PR are markedly influenced by the symptom severity at baseline, and by the likelihood of receiving active treatment in placebo-controlled trials.
Serotonin syndrome induced by dextromethorphan (Medicon) administrated at the conventional dose
A case of serotonin syndrome induced by dextromethorphan administrated at the conventional dose is reported for the first time in Japan, and it is established that this patient with chronic hepatitis with hepatitis C virus and chronic renal dysfunction had experienced the same symptoms after treatment with dextromexorphan 5 years earlier.
Intact pain modulation through manipulation of controllability and expectations in aging
This study assessed age‐related brain changes associated with pain expectation and controllability in men and women aged 40 and over.


Mechanisms of placebo and placebo-related effects across diseases and treatments.
Recent research has revealed that these psychosocial-induced biochemical changes in a patient's brain and body in turn may affect the course of a disease and the response to a therapy.
Placebos in clinical practice and research.
The authors provide examples in neuropsychiatry, illustrating that objective scientific data and well-considered guidelines may solve the ethical dilemma, and placebo control might even be considered an ethical obligation.
Do "placebo responders" exist?
The placebo effect should be looked upon as an epiphenomenon of complicated psychological processes, which are far more important than the disarmingly simple means utilized for its realization.
The placebo effect in heart failure.
  • M. Packer
  • Medicine, Psychology
    American heart journal
  • 1990
Placebo response in studies of major depression: variable, substantial, and growing.
The response to placebo in published trials of antidepressant medication for MDD is highly variable and often substantial and has increased significantly in recent years, as has the response to medication.
A comprehensive review of the placebo effect: recent advances and current thought.
The demonstration of the involvement of placebo mechanisms inclinical trials and routine clinical practice has highlighted interesting considerations for clinical trial design and opened up opportunities for ethical enhancement of these mechanisms in clinical practice.
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
Although placebos had no significant effects on objective or binary outcomes, they had possible small benefits in studies with continuous subjective outcomes and for the treatment of pain.
Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials
It is suggested that placebo interventions can improve physical disease processes of peripheral organs more easily and effectively than biochemical processes.